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Abstract. Cerenkov radiation (CR) is the emission of UV-vis light generated by the de-excitation of the
molecules in the medium, after being polarized by an excited particle traveling faster than the speed of light.
When β particles travel through tissue with energies greater than 219 keV, CR occurs. Tissues possess
a spectral optical window of 600 to 1100 nm. The CR within this range can be useful for quantitative preclinical
studies using optical imaging and for the in-vivo evaluation of 177Lu-radiopharmaceuticals (β-particle emitters).
The objective of our research was to determine the experimental emission light spectrum of 177Lu-CR and evalu-
ate its transmission properties in tissue as well as the feasibility to applying CR imaging in the preclinical studies
of 177Lu-radiopharmaceuticals. The theoretical and experimental characterizations of the emission and trans-
mission spectra of 177Lu-CR in tissue, in the vis-NIR region (350 to 900 nm), were performed using Monte Carlo
simulation and UV-vis spectroscopy. Mice 177Lu-CR images were acquired using a charge-coupled detector
camera and were quantitatively analyzed. The results demonstrated good agreement between the theoretical
and the experimental 177Lu-CR emission spectra. Preclinical CR imaging demonstrated that the biokinetics of
177Lu-radiopharmaceuticals in the main organs of mice can be acquired. © The Authors. Published by SPIE under a Creative
Commons Attribution 4.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication,
including its DOI. [DOI: 10.1117/1.JBO.24.7.076002]
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1 Introduction
Cerenkov radiation (CR) is the energy produced in the ultravio-
let (UV)-visible region of the electromagnetic spectrum, when
the charged particles in a medium travel faster than the speed of
light in the same medium. Because of the high particle velocity,
the molecules of the medium are polarized and are immediately
de-excited by releasing energy in the form of UV and visible
radiation. CR generation is related to the velocity and energy of
the particles as well as the refractive index of the environment.
The threshold condition for CR generation is vp > c∕n, where
n is the refractive index of the medium, and vp and c are
the speed of the particle and the speed of light in vacuum,
respectively.1,2 For β particles traveling in water (n ¼ 1.33), the
energy threshold for CR generation is 261 keV, and it changes
in muscle tissue (n ¼ 1.4) to 219 keV.3
The variability of the tissue refractive index plays an impor-
tant role in the production of photons through CR. The shape of
the CR spectrum is independent of the radionuclide, but the
intensity is regulated by the β particle source. Therefore, the
CR intensity is determined by the radionuclide radioactive decay
scheme and the number of transitions per unit time (activity).
For example, β particles with higher end-point energy (Emax)
will result in the emission of more Cerenkov photons.4
The optical imaging of radiopharmaceuticals using CR is
a preclinical molecular imaging modality that describes the
distribution, in time and space, of the charged-particle emitters
through the tissue, using highly sensitive charge-coupled
detectors (CCDs).5,6 This imaging modality has advantages,
such as lower infrastructure cost, higher resolution, and lower
image acquisition time, compared to micropositron-emission
tomography (PET),7,8 a conventional nuclear imaging technique
widely used.
177Lu is a radionuclide β emitter, with a half-life of 6.71 days
and Emax emission of 0.497 MeV (78%). It has been success-
fully used for radiopeptide therapy with an efficient crossfire
effect in cancer cells.9,10 Hence the development of new
177Lu-radiopharmaceuticals is of immense interest in the global
medical field.11
Some of the β particles emitted by 177Lu reach the relativistic
limit because they travel faster than the speed of light in different
media. Nevertheless, to successfully use 177Lu for applications
in preclinical CR imaging, it is necessary to establish several
physical parameters, such as the 177Lu-CR emission spectrum
in the tissue optical window (600 to 1100 nm),12 number of pho-
tons produced per unit of 177Lu activity considering the loss of
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energy in its path through the tissue, 177Lu-CR transmission
spectrum in the tissue, and the maximum depth at which the
177Lu source should be located in the tissue to obtain CR signals
suitable for imaging. These parameters, so far unknown, deter-
mine the applicability of 177Lu-CR in the preclinical assessment
(biokinetic models) of 177Lu-radiopharmaceuticals, based on
the optical images obtained in murine models.1,2,13,14
The objective of this work was to determine the experimental
emission light spectrum of 177Lu-CR, and evaluate its transmis-
sion properties in tissue as well as the feasibility of using CR
imaging in the preclinical studies of 177Lu-radiopharmaceuti-
cals. For this purpose, the theoretical and experimental charac-
terizations of the emission and transmission of CR generated
by 177Lu in tissue were performed using the Frank–Tamm and
relativistic theory, Monte Carlo simulation (MCLTmx code),
and UV-vis spectroscopy techniques. The 177Lu-CR images of
mice were acquired using a CCD camera. The total number of
photons per unit time per unit area (p∕s∕mm2) was quantita-
tively analyzed in each region of interest to obtain the total num-
ber of disintegrations, N ([MBq*h/MBq]), and the biokinetic
models in the kidneys and tumor regions.
2 Materials and Methods
2.1 Theoretical Characterization of 177Lu-CR
From the emission spectrum of 177Lu β particles (Emax ¼
0.497 MeV), the threshold energies required for CR generation





where c is the speed of light in vacuum, n is the refractive index
of the medium, and υp is the speed of the emitted β particle,
which can be calculated using Eq. (2). Here, E0 is the energy









The number of photons produced (∂N) over the distance trav-
eled (∂x) by the β particle was obtained using the Frank–Tamm
formula depicted in Eq. (3),15 which mathematically describes
the light dependence with respect to the radionuclide energy and















where α is the fine-structure dimensionless constant (1/137),
B is the ratio of the particle velocity to the speed of light,
n is the refractive index of the medium, and λ1 and λ2 are the
inferior and superior wavelengths of the emission spectrum,
respectively.
The mean range (R) of the charged particles is an extensively
used parameter in nuclear medicine.16 Here, R is defined as
the average linear scope of the charged particle in a material
medium; for β particles, it can be determined using Eqs. (4)
and (5):
EQ-TARGET;temp:intralink-;e004;63;102 m ¼ 412E1.265−0.0954 ln Emaxmax 0.01 < Emax < 2.5 MeV; (4)
EQ-TARGET;temp:intralink-;e005;326;741 m ¼ 530Emax − 106Emax > 2.5 MeV; (5)
where Emax is the maximum energy of the emitted particle and
Rm is the mass range in milligram per square centimeter.
To obtain the mean range in a medium or material, Rm is
divided by the density of the material (ρwater ¼ 1.00 g∕cm3 and
ρtissue ¼ 1.07 g∕cm3).
2.2 Experimental 177Lu-CR Emission Spectrum
177Lu was procured from ITG Isotope Technologies, with
a radionuclidic purity of 99.9% and activity of 37 GBq in
2 mL of 0.04 of hydrochloric acid (HCl) within a glass ampoule
vial. To characterize the CR emission spectrum, a BLUE-wave
optical fiber spectrometer (StellarNet Inc.) was used; the spec-
trum was obtained within the 350- to 900-nm range.
An experimental setup was designed, including the construc-
tion of a lead-shielded insulated dark chamber with a circular
aperture for the optical fiber. A glass ampoule vial was placed
within the chamber and an optical fiber was placed in contact
with the vial. This arrangement isolated the system from the
background light and protected the involved personnel from
the 177Lu ionizing radiation.
The 177Lu-CRðλÞ emission spectrum [gross spectrum,
177Lu-CRgrossðλÞ] was registered continuously in the 350- to
900-nm range. In addition, the background spectrum was
monitored similarly. The transmission spectrum (T) of the
empty glass ampoule vial was also recorded in a Perkin Elmer
spectrophotometer (model 551S) in the same wavelength range
(350 to 900 nm). The absorption spectrum of only one wall of
the vial (Abswall vial) was obtained as follows:





Finally, the absorption of the optical fiber (Absfiber) was
also determined. In this case, the StellarNet spectrophotometer
was illuminated with an aligned white light source and the trans-
mission spectra in the presence (I) and the absence (I0) of the
optical fiber were collected. From these spectra, the absorption
spectrum in the range from 350 to 900 nm was determined as
follows:




All obtained spectra were normalized. The final 177Lu-CR
emission spectrum [177Lu-CRðλÞ] corrected by background,







2.2.1 Validation of the experimental 177Lu-CR emission
spectrum
The experimental 177Lu-CRðλÞ emission spectrum was validated
using the CR spectrum of 68Ga reported by Thorek et al.,2 be-
cause CR generation phenomenon does not depend on the type
of radionuclide. Gallium-68 is a positron emitter that has a half-
life of 68 min with a βþ particle (Emax ¼ 1.9 MeV) abundance
of 89%. The validation was performed by a point-by-point
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comparison of the normalized CR values reported by Thorek
et al.2 and the normalized values obtained from the experimental
177Lu-CRðλÞ spectrum in the spectral range of 380 to 600 nm.
It is to be noted that Thorek et al. only reported the CR spectrum
in the 300- to 600-nm range; hence the 177Lu-CRðλÞ emission
spectrum emitted in the tissue optical window is unknown.
2.3 Determination of the Optical 177Lu-CR
Transmission in Tissue
Initially, the light transmission profile through tissue was
obtained by visible photon transport simulation using the
MCLTmx code.17 The 177Lu-CR light transmission in tissue
(transmission efficiency) was then obtained by the product of
the experimental 177Lu-CRðλÞ emission spectrum and the light
transmission profile simulated by the Monte Carlo MCLTmx
code at different wavelengths and tissue thicknesses. Finally,
the percentage of total emergent photons from the tissue optical
window was obtained as a sum of the integrals of each function
of the 177Lu-CRðλÞ transmission efficiency in the 600- to
900-nm range.
2.3.1 Light-transmission profile in tissue using
the Monte Carlo MCLTmx code
The Monte Carlo MCLTmx code simulates a monoenergetic and
isotropic point source, because the beta emitter (177Lu) was
considered homogenously distributed within the interest region
(tumor and kidneys). Since the beta emission is isotropic,
CR emission is also isotropic.
The source was located at the center of a biological tissue
plate of finite thickness and sides with the following girth at
each side of the source: 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7,
0.8, 0.9, 1, 1.2, 1.4, 1.5, and 2 cm. For each girth, photons with
the following wavelengths were, respectively, generated: 350,
400, 450, 500, 550, 600, 650, 700, 750, 800, 850, and 900 nm.
The reduced dispersion coefficient ½μ 0sðλÞ was obtained
using Eq. (9), and the anisotropy ½gðλÞ was calculated using18







EQ-TARGET;temp:intralink-;e010;63;283gðλÞ ¼ 0.943 − 5.6e−0.0084λ: (10)
Using Eqs. (9) and (10), the dispersion coefficient was
obtained through Eq. (11). The absorption coefficient, as a func-
tion of the wavelength ½μaðλÞ, was obtained from the Svaasand-
1995 data reported by Lister et al.,19 which can be considered an




1 − gðλÞ ; (11)
EQ-TARGET;temp:intralink-;e012;63;152
μaðλÞ ¼ 5.54þ 2939.68

32.7
4ðλ − 414.8Þ2 þ 32.72







if 510≤ λ≤ 900ðnmÞ:
(13)
The Svaasand-1995 data were reported for μaðλÞ, ranging
from 350 to 750 nm, which was extrapolated to obtain the μaðλÞ
values for wavelengths between 750 and 900 nm using Eq. (13).
Finally, the primary and secondary transmission data were
collected through a tissue plate. A total of 107 histories were
run; three runs were conducted for each wavelength.
2.4 177Lu-CR Image Acquisition and Quantitative
Analysis
T47D human breast cancer tumors were induced subcutane-
ously in 8-week-old athymic mice weighing 22 g. All the
studies on athymic mice were conducted according to the offi-
cial Mexican norm, 062-ZOO-1999.
177Lu-radiopharmaceutical with a radiochemical purity of
>98% was administered. The preparation of the radiopharma-
ceutical was previously reported by Aranda-Lara.20
177Lu-CR and x-ray images were acquired using Bruker’s
in-vivo xtreme (BVX) system which is a preclinical multimodal
imaging system that records images using different modalities
(radiographic, radioisotopic, fluorescence, and Cerenkov lumi-
nescence) through an ultrathin phosphor screen and CCD cam-
era. All the images were acquired and reconstructed following
the methodology reported by Ramírez-Nava.21 Briefly, CR and
x-ray images of the mice were acquired, as represented in Fig. 1,
with BVX and its multimodal animal rotation system (MARS)
after the administration of 177Lu (2, 4, 24, 48, and 120 h). Each
177Lu-CR acquisition gathered a set of 13 projections, covering
the 360 deg of rotation (30-deg steps). The acquisition time of
each projection was 5 min, the binning was 4 × 4, in a field of
view (FOV) of 12.5 cm.
The x-ray images were used to obtain the anatomical
tomographic reconstruction of the rodents. These images were
registered with a tube voltage of 45 kVp, a current of 497 μA,
and an aluminum filter of 0.8 mm. In this modality, a batch of
Fig. 1 Schematic representation of x-ray and Cerenkov images
acquisition using BVX system and projection images acquired with
MARS.
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181 projections (360-deg coverage and 2-deg steps) was acquired.
The acquisition time of each projection was 10 s, using a 1 × 1
binning, and a 12.5-cm FOV. Both CR and x-ray images were
reconstructed with the filtered backprojection algorithm, which
was implemented in MATLAB R2108b (MathWorks, 2018).
The regions of interest (kidneys and the tumor) were located
in the planar images of mice. From the 13 projection images
acquired with the MARS, the mean depth of the tumor and
kidneys were determined. The 177Lu-CR images were quantita-
tively analyzed by counting the photons per unit time per unit
area (p∕s∕mm2) in each region of interest.
2.4.1 Determination of the total number of p/s/mm2 as
a function of the activity
The total activity in the regions of interest was determined by
calibrating the CCD camera, by counting the total number of
p∕s∕mm2 detected by it from different known radiation activ-
ities (0.5, 1, 2, 4, 8, and 16 MBq). The mathematical function
describing p∕s∕mm2 as a function of the activity was then
obtained.
Biokinetic models [AhðtÞ] for the tumor and kidneys were
constructed using the activity registered at 2, 4, 24, 48, and
120 h postinjection in the regions of interest, and the number of
total disintegrations (N) normalized to the unit-administered






The total number of disintegrations, Nregion, obtained was
compared with that obtained through a method involving the
counting of the activity in a well-type scintillation detector from
ex-vivo organs, reported by Aranda-Lara et al.20
Fig. 2 (a) Energy spectrum of the β particles emitted by 177Lu, reported by radiation dose assessment
resource24 and (b) relationship between β energy and their velocity in water (n ¼ 1.33) or tissue
(n ¼ 1.34–1.36); the star represents the energy at which CR can be produced. (c) Number of photons
produced by unit of β particle traveled path obtained with the Frank–Tamm theory in water and tissue, and
(d) mean ranges of β particles emitted by 177Lu in water and tissue determined by nuclear medicine
technique.16
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3 Results and Discussion
3.1 Theoretical Characterization of 177Lu-CR
Figure 2 shows the theoretical characterization of the physical
properties of 177Lu. Figure 2(a) presents the energy spectrum of
the β particles emitted by 177Lu; Fig. 2(b) depicts the relation-
ship between the energy and velocity in water (n ¼ 1.33) and
the tissue (n ¼ 1.34 to 1.36); Fig. 2(c) displays the number of
photons produced by the traveling of the emitted β particles for
unit distance. This number was obtained using the Frank–Tamm
equation in different media (water and tissue); Fig. 2(d) depicts
the linear range (R) of the β particles in water and tissue.
It can be observed that the threshold energy necessary for CR
generation in water and tissue are 246.06 keV and 219.19 to
242.97 keV, respectively, depending on the tissue refractive
index. Around 25% of the β particles emitted by 177Lu presented
an energy greater than the threshold energy required for CR
generation. The R, where the β particles can produce CR, was
∼1 cm in water and 0.9 cm in tissue. This characteristic is
important in image reconstruction because it enables the
improvement of the spatial and temporal resolutions of the
image by differentiating between the material interfaces.22,23
Moreover, the number of the total photons produced per unit of
activity can be calculated by the functions shown in Fig. 2(c),
corrected by the probability of emission of the β particle
[Fig. 2(a)]; in the case of water, the total numbers of photons
by a unit of activity was 556,089.
3.2 Experimental 177Lu-CR Emission Spectrum
Thorek et al.2 previously reported the Cerenkov spectrum of
68Ga, and since this spectrum does not depend on the type of
radionuclide used, it is expected that the normalized CR spec-
trum of 177Lu is equal to that of 68Ga. In a previous work, CR
spectrum was recorded from 68Ga but for wavelengths lower
than 600 nm. In this work, the area of interest is the optical win-
dow of the tissue (λ > 600 nm), therefore CR spectrum was
recorded from 177Lu reaching the wavelength of 900 nm.
Figure 3 shows the experimental CR emission spectrum,
corrected for the background, glass vial, and optical fiber
absorption. The spectral range of the tissue optical window
(600 to 900 nm) is an important contributor to the total intensity
of the spectrum.
Figure 4(a) shows the normalized emission spectrum of
68Ga reported by Thorek et al.,2 while Fig. 4(b) presents the
normalized experimental 177Lu-CR spectrum of 177Lu obtained
in this study. Figure 4(c) depicts the comparison between the
experimental 177Lu-CR spectrum and that reported by Thorek
et al.2 The comparison does not show significant differences
in the 380 to 600 nm spectral window (<2%) because CR gen-
eration does not depend upon the radionuclide and only depends
on the emission energy. Thus, this result validates the complete
177Lu-CR spectrum (380 to 900 nm). The results of the normal-
ized experimental characterization demonstrated that 45% of the
total intensity of the 177Lu-CR emission spectrum corresponds
to the photons within the tissue optical window, supporting pos-
sible applications for the acquisition of optical images similar to
those of positron emitters (e.g., 18F, 64Cu, and 89Zr).8,25,26
Table 1 shows the mathematical models that describe the
normalized 177Lu-CR experimental emission spectrum; the
mathematical models for the two subregions (380 to 600 nm and
600 to 900 nm) are indicated.
3.3 Determination of the Optical Transmission
177Lu-CR in Tissue
In general, light transport by Monte Carlo method is performed
in models that consider turbid homogeneous media or multi-
layer.27,28 But if it is considered that the refraction index is sim-
ilar for different biological tissues (skin, brain, liver, kidneys,
etc.), then a homogeneous media can be simulated, using ab-
sorption and scattering coefficients that represent various tissues
and blood as a “generic tissue.”12,27,29 In this work, one layer of
such tissue was considered in the simulation.
In Fig. 5, the normalized values of the light transmission
for different tissue thicknesses obtained by Monte Carlo simu-
lation are presented. As expected, greater light transmission was
obtained in the 600- to 900-nm wavelength interval, which
falls within the interval of the tissue optical window (600 to
1100 nm), where the tissues become optically transparent.12
Considering the general light transmission profile as a func-
tion of the wavelength at different tissue thicknesses (Fig. 5),
as well as the experimental 177Lu-CR emission spectrum, the
efficiency of the Cerenkov light transmission generated by 177Lu
at different tissue thicknesses and wavelengths was obtained
(Fig. 6).
Figure 7 shows the percentage of the total emergent photons
in the tissue optical window. It was calculated as the sum of
the integral of each 177Lu-CR transmission efficiency function
obtained at different tissue thickness in the 600- to 900-nm range.
Given the fact that the main organs of mice have an average
depth of 1.25 cm (liver, kidney, spleen, intestine, lungs, heart,
and induced tumors)30 it can be seen from Fig. 7 that about
20% of the photons produced emerged from tissue. This percent-
age sustains the potential acquisition of images from the CR,
which supports the biokinetics of 177Lu-radiopharmaceuticals
in the main organs of mice. Nevertheless, the imaging correction
factors due to the overlapping of organs must be determined
for improving the quantification by the optical imaging of the
parameters related to the 177Lu-radiopharmaceutical biokinetics.
The function fitting of the percentage of total emergent
photons from the tissue optical window with respect to the
depth is represented in Eq. (15), where A ¼ 33.51, B ¼ 41.60,
C ¼ 42.01, D ¼ 1.3187, a ¼ 0.12, b ¼ 0.95, and c ¼ 0.95.
Fig. 3 Experimental CR spectrum, corrected for background, glass
vial, and optical fiber absorption, obtained in the wavelength range
from 300 to 900 nm.
Journal of Biomedical Optics 076002-5 July 2019 • Vol. 24(7)
Jiménez-Mancilla et al.: Theoretical and experimental characterization of emission. . .
Downloaded From: https://www.spiedigitallibrary.org/journals/Journal-of-Biomedical-Optics on 17 Oct 2019
Terms of Use: https://www.spiedigitallibrary.org/terms-of-use
The inverse of this function can be considered as the tissue
attenuation function; knowing the percentage of the total
emergent photons at the tissue depth to be studied, the optical
image can be corrected by the attenuation factor
EQ-TARGET;temp:intralink-;e015;63;109%total emergent photons ðdepthÞ
¼ Aeð−depth∕aÞ þ Beð−depth∕bÞ þ Ceð−depth∕cÞ −D: (15)
3.4 177Lu-CR Image Acquisition and Quantitative
Analysis
The 177Lu-CR images of mice acquired using the BVX, and
reconstructed as per the methodology reported by Ramírez-
Nava et al.21 at 2 and 24 h, are depicted in Fig. 8; images were
also acquired at 4, 48, and 120 h. The quantitative analysis of
the 177Lu-CR images shows that the mean depths of the tumor
Fig. 4 (a) Normalized emission spectrum of 68Ga reported by Thorek et al.2 (b) Normalized emission
spectrum of 68Ga obtained from the original spectrum, which was reported by Thorek et al.2
(c) Comparison between both CR spectra obtained in the spectral range from 380 to 600 nm.
Table 1 Normalized mathematical model of the experimental 177Lu-
CR emission spectrum in the spectral ranges of 350 to 600 nm and
600 to 900 nm.
Mathematical model IðλÞ
IðλÞ ¼ Aþ B − C
1þ 10ða−λÞð−bÞ
Wavelength (nm) Constant values R-square












Fig. 5 Light transmission profile for different thicknesses of tissue
as a function of the wavelength obtained by Monte Carlo simulation
(MCLTmx code).
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and kidneys are 0.4 and 0.9 cm, respectively. The number of
photons per unit time per unit area (p∕s∕mm2) in the kidneys
and tumor at different time durations and their correction by
the attenuation factor are listed in Table 2.
The total activity in MBq found in the kidneys and tumor at
different time durations (Table 3) was obtained from Eq. (16),
which relates the photons per unit time per unit area as a func-
tion of the activity. Equation 16 was obtained from the calibra-
tion curve of the CCD in-vivo xtreme system as the function of
different activities (MBq) (Fig. 9). In Table 3, the biokinetic
models in both regions of interest are also presented. It is to
be noted that for obtaining high-quality optical images, it is nec-
essary to characterize the CCD, including its limit of detection,
dependence of the limit of detection on the production of pho-
tons, and its dependence on the initial activity because low
signal intensity relative to the CR is a major limitation. Tamura
et al.7 argue that preclinical instrumentation should focus on
maximizing the light generated by a radionuclide source, while
minimizing the light loss (by absorbance in the optical path)
related to the detector wavelength sensitivity. Solving these
shortcomings, the clinical translation to in-vivo models can
be accelerated
EQ-TARGET;temp:intralink-;e016;326;510 ∕s∕mm2 ðActivityÞ ¼ A − BeðActivity∕aÞ; (16)
where A ¼ 13321.9803, B ¼ 13302.702, and a ¼ −18.980.
Finally, the total number of disintegrations, N (MBq*h/
MBq), in the kidneys and tumor obtained by the integration
over time of the biokinetic models are presented in Table 4.
The results obtained in this study using 177Lu-CR imaging and
Monte Carlo simulation do not significantly differ (<3%) with
those obtained from an ex-vivo model that used the same 177Lu-
radiopharmaceutical reported by Aranda-Lara et al.20
Various biomolecules, peptides, and proteins labelled as 18F,
90Y, 64Cu, 68Ga, 89Zr, 177Lu, etc., are administered for specific
diseases. These radiopharmaceuticals, which have demonstrated
significant improvement in the condition and life quality of
patients,31,32 can also generate CR. Several authors have men-
tioned that in addition to their use in PET or SPECT, they have
significant potential for employment in preclinical studies using
optical image evaluation techniques. Owing to the absorption
of the CR generated in human tissue, optical imaging by
CR cannot be used in clinical studies. Nevertheless, optimal
Fig. 6 Cerenkov light transmission profile generated by 177Lu at
different tissue thicknesses (efficiency of transmission) obtained by
the product of the experimental 177Lu-CR spectrum [Fig. 4(a)] and
the light transmission profile (Fig. 5).
Fig. 7 Percentage of transmission of total photons in the optical
spectral window with respect to depth and its function fitting.
Fig. 8 Tridimensional fusion of 177Lu-CR (green color) and x-ray images of mice acquired in a Bruker’s
in-vivo xtreme system at times 2 and 24 h.
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characterization of the CR images can improve the image res-
olution because CR generation takes place close to the point
where radioactive disintegration occurs and therefore, less
image reconstruction would be required in comparison with the
PET reconstruction techniques.7,8,33
It has been reported that the CR optical image technique is
better characterized for evaluating tissue under hypoxia.34 This
Table 2 Number of photons per unit time per unit area (p∕s∕mm2) for tumor and kidneys at different times obtained from the optical images and




2 4 24 48 120
Kidneys 0.9 1950.85 35.61 1840.15 33.59 649.46 11.85 418.21 07.63 324.73 05.93
Tumor 0.4 2361.25 43.35 2150.36 39.47 986.68 18.11 643.98 11.82 591.25 10.85
Experimental data corrected by the attenuation factor [Photons∕s∕mm2  100∕% Transmission of total photons (depth)]
Kidneys 0.9 6211.02 113.37 5858.56 106.93 2067.73 37.74 1331.49 24.30 1033.86 18.87
Tumor 0.4 4251.77 78.05 3872.02 71.08 1776.66 32.61 1159.57 21.29 1064.64 19.54




2 4 24 48 120
Kidneys 11.89 0.31 10.97 0.27 3.18 0.06 1.97 0.04 1.51 0.03
Tumor 7.27 0.16 6.49 0.14 2.69 0.05 1.70 0.03 1.55 0.02
Biokinetic models
AhðtÞ ¼ Ae−at  Be−bt
Constant values
Kidneys A ¼ 12.40 B ¼ 1.62
a ¼ 8.07E − 2 b ¼ 5.70E − 4
Tumor A ¼ 6.65 B ¼ 1.53 − 9
a ¼ 7.31E − 2 b ¼ 5.00E
Table 4 Total number of disintegrations N (MBq*h/MBq) obtained in
this research by optical imaging and the comparison with that reported
by Aranda-Lara et al.20 from an ex-vivo method.
Tissue






Kidneys 4.88 0.19 4.75 0.67
Tumor 4.40 0.09 4.33 0.31
Fig. 9 Calibration of the CCD in-vivo xtreme system and function
fitting.
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technique is the only one that can be corroborated by other im-
aging techniques, such as the PET or SPECT (different imaging
principle). Moreover, it has additional advantages compared to
the traditional nuclear medicine imaging techniques in terms of
the cost, rapidity of image acquisition, and image evaluation.7,8
4 Conclusions
This study presented a methodology based on the theoretical
and experimental characterizations of the generation and range
of 177Lu-CR. By Monte Carlo simulation, the absorption and/or
attenuation parameters in tissue were established and subse-
quently, the biokinetic model of the 177Lu-radiopharmaceutical
was successfully obtained.
The results of experimental characterization showed that
45% of the total intensity of the 177Lu-CR emission spectrum
corresponds to photons with energies within the tissue optical
window. The total percentage of emerging photons as a function
of the depth of 177Lu-CR, obtained by Monte Carlo simulation
and the experimental spectrum of 177Lu-CR, demonstrated that
emergent photons existed even at a tissue depth of 1.25 cm
(average depth of main organs of mice). The results obtained
from the preclinical 177Lu-CR images agreed with the theoreti-
cal transmission spectrum and demonstrated that the biokinetics
of 177Lu-radiopharmaceuticals in the main organs of mice can be
acquired from the CR optical images. The results indicate that
177Lu can be applied for the acquisition of optical images by
CR generation in tissue and can be implemented in routine pre-
clinical studies. 177Lu-CR optical images are an alternative for
the preclinical evaluation of new 177Lu-radiopharmaceuticals.
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